SAB Biotherapeutics Inc (NAS:SABS) Stock News, Headlines & Updates
SAB Biotherapeutics Inc Stock News from GuruFocus
- 1
May 15, 2025
SABS Maintains Buy Rating by Chardan Capital with $20 Target | SABS Stock News
GuruFocus News • 11:01am
May 14, 2025
SAB Biotherapeutics (SABS) Receives New "Buy" Rating from Analyst | SABS Stock News
GuruFocus News • 12:31pm
SAB Biotherapeutics (SABS) Receives Buy Rating and $10 Target from H.C. Wainwright | SABS Stock News
GuruFocus News • 5:56am
May 09, 2025
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
Marketwired • 9:00am
SAB BIO (SABS) Reports Cash Decrease as Progress in T1D Therapy Advances | SABS Stock News
GuruFocus News • 8:20am
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates | SABS Stock News
GuruFocus News • 8:16am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news